Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
In this study, we revealed that equine major histocompatibility complex (MHC) class I binds to equine herpesvirus type 4 (EHV-4) glycoprotein D and mediates the cellular entry of EHV-4. We also showed that the treatment of recombinant proteins binding to equine MHC class I inhibits the entry of both EHV-1 and EHV-4, suggesting that the blocking of equine MHC class I will be a candidate for the prevention and treatment of EHV-1 and EHV-4 infections. In addition, we analyzed the function of rabbit MHC class I in EHV-1 entry into RK13 cells.
|